Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-25 @ 8:53 PM
Study NCT ID:
NCT00420056
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2007-01-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-05
First Submit QC Date:
None
Study First Post Date:
2007-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-04
Results First Submit QC Date:
None
Results First Post Date:
2015-06-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-06
Last Update Post Date:
2015-10-28
Last Update Post Date Type:
ESTIMATED